Investor Ideas ‘Potcast’; #Cannabis
News and Stocks on the Move- Canopy Growth (TSX: $WEED.TO, NYSE: $CGC),
Maricann Group, Sunniva
Pt. Roberts, WA; Delta, BC –, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its new series, Investorideas.com potcasts - cannabis news
and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this news in full at http://www.investorideas.com/news/2018/cannabis/05301Potcast-TSXWEEDNYSECGC.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast –
looking at cannabis news, stocks to watch as well as insights from thought leaders
and experts. Today we are looking at announcements from Canopy Growth (TSX: WEED,
NYSE:CGC), Maricann Group Inc. (CSE:MARI and OTCQB
:MRRCF), and Sunniva
Inc. (CSE:
SNN and OTCQX:
SNNVF).
First
looking at Canopy Growth Corporation who announced that the they’ve acquired
Daddy Cann Lesotho PTY Ltd., trading as Highlands.
Based in the
Kingdom of Lesotho, Highlands holds a license to cultivate, manufacture,
supply, hold, import, export and transport cannabis and its resin. Lesotho is a
high altitude mountainous kingdom that boasts over 300 days of sunshine per
year and was the first African nation to legalize medical cannabis in 2017. It
has ideal humidity and growing conditions for greenhouse cultivation. Together
with very low operating and resource costs, this places Canopy Growth in a
position to produce large quantities of high quality medical cannabis at a low
cost. Lesotho is also strategically positioned for the future medical cannabis
economy of Southern Africa including the potential market of South Africa, with
a population of over 55 million people, where medical cannabis laws are being
developed.
"Lesotho
is Canopy Growth's first step into Africa and we look forward to working with
the strong local team at Highlands to establish production and distribution
capabilities consistent with Canopy's global standard for high-quality,
regulated medical cannabis products," said Mark Zekulin, President, Canopy
Growth.
Combining
the domestic and regional knowledge of Highlands with the global experience and
expertise of Canopy Growth is the latest example of the Company establishing a
meaningful local presence. With the objective of future local production to
serve the regional market, these operations are part of Canopy Growth's
commitment to the Lesotho economy including supporting job creation and lasting
community engagement.
All key
members of Highlands's management team will continue to lead the organization
as part of the Canopy Growth family.
"We're
excited to join the Canopy Growth family and bring together our strong
entrepreneurial experience and local knowledge in the region with Canopy
Growth's track record and quality standards in the global medical cannabis
industry," said Jody Aufrichtig, Founder, Highlands. "Lesotho and
Southern Africa have enormous potential and we look forward to building a
responsible medical cannabis business across the region."
Maricann
Group Inc. reported its financial and operating results for the first quarter ended
March 31, 2018 and has filed the full report on SEDAR. All figures are stated in Canadian Dollars.
Maricann recognized revenue of $600,591, down from $1,143,167 in Q1 of 2017.
The decline in revenue can be explained by the timing of a large bulk
transaction of Switzerland-based cannabis cultivator HAXXON AG which
subsequently closed in Q2. As a result, current sales for Q2 of 2018 total
approximately $905,000 to date (unaudited).
Consistent
with previous guidance, the Company is positioned for export to the European
market, having achieved European Medicines Agency Good Manufacturing Practice
(EMA-GMP) certification for its facilities at 150 8th Concession
Road, Langton ON (“Site 150”), a prerequisite to export cannabis to the
European Union. Additionally, the Company is preserving inventory for both
export to Europe and the adult use market in Canada, when legal.
“We maintain
our position that establishing sustainable baskets of margin for our products
that will be preserved over the long term is more important than immediate
gross revenue. We base all our business decisions in the interest of long term
value creation for our shareholders,” Stated Ben Ward, CEO.
Some Other Highlights for the quarter include:
·
Strengthened
the Company’s balance sheet by raising $40,250,000 by way of private placement.
·
Positioned
with Provinces for supply to the upcoming recreational market.
·
Signed an
exclusive agreement with Colorado-based Rare Dankness to provide their
award-winning genetics to the Canadian market. Rare Dankness is a multi-year
winner of the prestigious Amsterdam Cannabis Cup.
·
The first room
in phase 1 of Maricann’s world class grow facility was ready for cultivation.
Subsequently, the Company received its third License from Health Canada to move
ahead with cultivation activities and is now propagating 2,639 plants in the
new facility.
And finally,
Sunniva Incorporated’s wholly-owned subsidiary, Natural Health Services Ltd.
("NHS"), Canada's largest referral network of medical cannabis
patients to Licensed Producers in Canada, held an open house for media and the
public, today at the grand opening of its clinic located at 7900 Anchor Drive
in Windsor, Ontario. The facility is one of seven owned and operated
patient-centric clinics operating in Alberta, Saskatchewan, Manitoba and
Ontario.
NHS provides
consultation, medical cannabis education and an introduction to the products
and strains available through Licensed Producers across Canada. NHS clinics are
staffed by physicians, nurses, educators and patient care representatives
on-site.
Investor ideas reminds all listeners to read
our disclaimers and disclosures
on the Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
on the Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment